RhumbLine Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-25,183
| Closed | -$15.6K | – | 4369 |
|
2024
Q2 | $15.6K | Sell |
25,183
-102,240
| -80% | -$63.2K | ﹤0.01% | 3907 |
|
2024
Q1 | $327K | Buy |
127,423
+3,747
| +3% | +$9.63K | ﹤0.01% | 2937 |
|
2023
Q4 | $252K | Sell |
123,676
-545
| -0.4% | -$1.11K | ﹤0.01% | 3070 |
|
2023
Q3 | $214K | Sell |
124,221
-5,832
| -4% | -$10K | ﹤0.01% | 3128 |
|
2023
Q2 | $254K | Buy |
+130,053
| New | +$254K | ﹤0.01% | 3109 |
|
2022
Q2 | – | Sell |
-56,865
| Closed | -$234K | – | 3266 |
|
2022
Q1 | $234K | Buy |
56,865
+1,170
| +2% | +$4.82K | ﹤0.01% | 2718 |
|
2021
Q4 | $716K | Buy |
55,695
+3,566
| +7% | +$45.8K | ﹤0.01% | 2353 |
|
2021
Q3 | $563K | Buy |
52,129
+1,900
| +4% | +$20.5K | ﹤0.01% | 2489 |
|
2021
Q2 | $459K | Buy |
50,229
+13,837
| +38% | +$126K | ﹤0.01% | 2600 |
|
2021
Q1 | $343K | Sell |
36,392
-2,100
| -5% | -$19.8K | ﹤0.01% | 2650 |
|
2020
Q4 | $152K | Buy |
38,492
+7,072
| +23% | +$27.9K | ﹤0.01% | 2900 |
|
2020
Q3 | $83K | Sell |
31,420
-5,396
| -15% | -$14.3K | ﹤0.01% | 2903 |
|
2020
Q2 | $244K | Buy |
36,816
+6,563
| +22% | +$43.5K | ﹤0.01% | 2675 |
|
2020
Q1 | $176K | Buy |
30,253
+1,950
| +7% | +$11.3K | ﹤0.01% | 2630 |
|
2019
Q4 | $254K | Buy |
28,303
+250
| +0.9% | +$2.24K | ﹤0.01% | 2672 |
|
2019
Q3 | $242K | Buy |
28,053
+2,774
| +11% | +$23.9K | ﹤0.01% | 2679 |
|
2019
Q2 | $282K | Buy |
+25,279
| New | +$282K | ﹤0.01% | 2631 |
|